#FGDebate: 解决肝病患者护理和结果的地区差异问题

IF 2.4 Q3 GASTROENTEROLOGY & HEPATOLOGY
Gemma Wells, Oliver D Tavabie, Stuart McPherson, Mohsan Subhani
{"title":"#FGDebate: 解决肝病患者护理和结果的地区差异问题","authors":"Gemma Wells, Oliver D Tavabie, Stuart McPherson, Mohsan Subhani","doi":"10.1136/flgastro-2024-102815","DOIUrl":null,"url":null,"abstract":"Liver disease is now the second highest cause of years of working life lost in Europe, only surpassed by ischaemic heart disease.1 The April #FGDebate based on the recent paper entitled ‘Regional variations in inpatient decompensated cirrhosis mortality may be associated with access to specialist care: results from a multicentre retrospective study’2 aimed to facilitate discussion around this topic. It highlighted a number of important themes; possible strategies to reduce disparities in care across the UK, challenges in hepatology training and supporting care delivery for patients with decompensated cirrhosis. In this article, we will expand on some of the key themes and discussions from this debate. ### Defining the issue Regional disparities in the provision of hepatology services and outcomes have been well-described historically3 as well as in multiple recent audits.2 4–6 Undoubtedly, this is partially explained by regional variation in social deprivation as well as public health policy including minimum unit pricing.7 However, access to specialist care and intervention has been repeatedly identified as a potential risk factor for adverse outcome. In the primary biliary cholangitis (PBC) study, patients in specialist centres were significantly more likely to be managed with appropriate second-line therapies and be referred for transplant assessment than those in non-specialist centres.6 Patients with metabolic-dysfunction-associated steatotic liver disease (MASLD) were more likely to have fibrosis assessment and comprehensive cardiometabolic assessment and management if they were managed in a centre with a multidisciplinary MASLD service.5 In patients presenting with decompensated cirrhosis, significant variations in mortality were seen between non-specialist centres which were not present in specialist centres.2 Additionally, lower consultant numbers corresponded to higher inpatient mortality in non-specialist centres, which was more likely to be the case in areas of higher social deprivation.2 There is also evidence from the USA and UK that …","PeriodicalId":46937,"journal":{"name":"Frontline Gastroenterology","volume":"41 1","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"#FGDebate: addressing regional variations in care and outcomes for patients with liver disease\",\"authors\":\"Gemma Wells, Oliver D Tavabie, Stuart McPherson, Mohsan Subhani\",\"doi\":\"10.1136/flgastro-2024-102815\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Liver disease is now the second highest cause of years of working life lost in Europe, only surpassed by ischaemic heart disease.1 The April #FGDebate based on the recent paper entitled ‘Regional variations in inpatient decompensated cirrhosis mortality may be associated with access to specialist care: results from a multicentre retrospective study’2 aimed to facilitate discussion around this topic. It highlighted a number of important themes; possible strategies to reduce disparities in care across the UK, challenges in hepatology training and supporting care delivery for patients with decompensated cirrhosis. In this article, we will expand on some of the key themes and discussions from this debate. ### Defining the issue Regional disparities in the provision of hepatology services and outcomes have been well-described historically3 as well as in multiple recent audits.2 4–6 Undoubtedly, this is partially explained by regional variation in social deprivation as well as public health policy including minimum unit pricing.7 However, access to specialist care and intervention has been repeatedly identified as a potential risk factor for adverse outcome. In the primary biliary cholangitis (PBC) study, patients in specialist centres were significantly more likely to be managed with appropriate second-line therapies and be referred for transplant assessment than those in non-specialist centres.6 Patients with metabolic-dysfunction-associated steatotic liver disease (MASLD) were more likely to have fibrosis assessment and comprehensive cardiometabolic assessment and management if they were managed in a centre with a multidisciplinary MASLD service.5 In patients presenting with decompensated cirrhosis, significant variations in mortality were seen between non-specialist centres which were not present in specialist centres.2 Additionally, lower consultant numbers corresponded to higher inpatient mortality in non-specialist centres, which was more likely to be the case in areas of higher social deprivation.2 There is also evidence from the USA and UK that …\",\"PeriodicalId\":46937,\"journal\":{\"name\":\"Frontline Gastroenterology\",\"volume\":\"41 1\",\"pages\":\"\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2024-08-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontline Gastroenterology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/flgastro-2024-102815\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontline Gastroenterology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/flgastro-2024-102815","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

1 四月的 #FGDebate 以最近发表的题为 "肝硬化失代偿期住院患者死亡率的地区差异可能与获得专科护理有关:一项多中心回顾性研究的结果 "2 的论文为基础,旨在促进围绕这一主题的讨论。该研究强调了一些重要的主题:缩小英国各地护理差异的可能策略、肝病学培训面临的挑战以及为失代偿期肝硬化患者提供护理支持。在本文中,我们将对此次辩论中的一些关键主题和讨论进行详细阐述。### 7 然而,获得专科治疗和干预的机会已被反复确认为导致不良后果的潜在风险因素。在原发性胆汁性胆管炎(PBC)研究中,与非专科中心的患者相比,专科中心的患者更有可能接受适当的二线治疗,并被转介接受移植评估。6 代谢功能障碍相关性脂肪性肝病(MASLD)患者如果在设有多学科 MASLD 服务的中心接受治疗,则更有可能接受纤维化评估以及全面的心脏代谢评估和管理。在失代偿期肝硬化患者中,非专科中心之间的死亡率存在显著差异,而专科中心则不存在这种差异。2 此外,非专科中心的顾问人数较少,相应的住院患者死亡率较高,而在社会贫困程度较高的地区,这种情况更有可能发生。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
#FGDebate: addressing regional variations in care and outcomes for patients with liver disease
Liver disease is now the second highest cause of years of working life lost in Europe, only surpassed by ischaemic heart disease.1 The April #FGDebate based on the recent paper entitled ‘Regional variations in inpatient decompensated cirrhosis mortality may be associated with access to specialist care: results from a multicentre retrospective study’2 aimed to facilitate discussion around this topic. It highlighted a number of important themes; possible strategies to reduce disparities in care across the UK, challenges in hepatology training and supporting care delivery for patients with decompensated cirrhosis. In this article, we will expand on some of the key themes and discussions from this debate. ### Defining the issue Regional disparities in the provision of hepatology services and outcomes have been well-described historically3 as well as in multiple recent audits.2 4–6 Undoubtedly, this is partially explained by regional variation in social deprivation as well as public health policy including minimum unit pricing.7 However, access to specialist care and intervention has been repeatedly identified as a potential risk factor for adverse outcome. In the primary biliary cholangitis (PBC) study, patients in specialist centres were significantly more likely to be managed with appropriate second-line therapies and be referred for transplant assessment than those in non-specialist centres.6 Patients with metabolic-dysfunction-associated steatotic liver disease (MASLD) were more likely to have fibrosis assessment and comprehensive cardiometabolic assessment and management if they were managed in a centre with a multidisciplinary MASLD service.5 In patients presenting with decompensated cirrhosis, significant variations in mortality were seen between non-specialist centres which were not present in specialist centres.2 Additionally, lower consultant numbers corresponded to higher inpatient mortality in non-specialist centres, which was more likely to be the case in areas of higher social deprivation.2 There is also evidence from the USA and UK that …
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Frontline Gastroenterology
Frontline Gastroenterology GASTROENTEROLOGY & HEPATOLOGY-
CiteScore
4.70
自引率
11.50%
发文量
93
期刊介绍: Frontline Gastroenterology publishes articles that accelerate adoption of innovative and best practice in the fields of gastroenterology and hepatology. Frontline Gastroenterology is especially interested in articles on multidisciplinary research and care, focusing on both retrospective assessments of novel models of care as well as putative future directions of best practice. Specifically Frontline Gastroenterology publishes articles in the domains of clinical quality, patient experience, service provision and medical education.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信